James H. Kocsis

16.0k total citations · 1 hit paper
178 papers, 10.4k citations indexed

About

James H. Kocsis is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, James H. Kocsis has authored 178 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Pharmacology, 86 papers in Psychiatry and Mental health and 67 papers in Experimental and Cognitive Psychology. Recurrent topics in James H. Kocsis's work include Treatment of Major Depression (91 papers), Bipolar Disorder and Treatment (48 papers) and Mental Health Research Topics (45 papers). James H. Kocsis is often cited by papers focused on Treatment of Major Depression (91 papers), Bipolar Disorder and Treatment (48 papers) and Mental Health Research Topics (45 papers). James H. Kocsis collaborates with scholars based in United States, Denmark and Germany. James H. Kocsis's co-authors include John C. Markowitz, Daniel N. Klein, Michael E. Thase, Rachel Manber, Bruce A. Arnow, A. John Rush, Madhukar H. Trivedi, Susan G. Kornstein, Martin B. Keller and Philip T. Ninan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

James H. Kocsis

173 papers receiving 9.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

2003 3.0k citations A. John Rush, Madhukar H. Trivedi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James H. Kocsis United States	55	3.9k	3.8k	3.5k	3.0k	1.3k	178	10.4k
David L. Dünner United States	60	6.3k 1.6×	3.2k 0.8×	3.1k 0.9×	3.5k 1.2×	1.1k 0.9×	266	13.6k
Thomas Carmody United States	50	3.9k 1.0×	3.0k 0.8×	3.0k 0.8×	2.9k 1.0×	1.2k 0.9×	209	11.5k
Philip T. Ninan United States	42	2.2k 0.6×	2.8k 0.7×	2.7k 0.8×	2.6k 0.9×	964 0.7×	111	8.7k
Jonathan E. Alpert United States	66	3.7k 0.9×	4.5k 1.2×	3.3k 0.9×	3.0k 1.0×	1.4k 1.0×	233	12.7k
Jan Fawcett United States	52	3.1k 0.8×	2.5k 0.7×	2.1k 0.6×	3.1k 1.0×	1.4k 1.1×	208	8.6k
Arun Ravindran Canada	53	3.8k 1.0×	3.3k 0.9×	1.9k 0.5×	2.6k 0.9×	1.2k 0.9×	192	10.8k
Kathy Shores‐Wilson United States	31	2.9k 0.7×	4.9k 1.3×	2.7k 0.8×	1.2k 0.4×	1.1k 0.8×	43	8.5k
Susan G. Kornstein United States	47	2.6k 0.7×	4.1k 1.1×	3.4k 0.9×	2.8k 0.9×	1.7k 1.3×	159	10.8k
Lewis L. Judd United States	52	7.9k 2.0×	2.9k 0.8×	3.0k 0.8×	4.3k 1.4×	2.1k 1.6×	147	14.7k
Robert H. Howland United States	46	2.7k 0.7×	4.6k 1.2×	2.6k 0.7×	1.4k 0.5×	1.0k 0.8×	221	10.1k

Countries citing papers authored by James H. Kocsis

Since Specialization

Citations

This map shows the geographic impact of James H. Kocsis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Kocsis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Kocsis more than expected).

Fields of papers citing papers by James H. Kocsis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Kocsis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Kocsis. The network helps show where James H. Kocsis may publish in the future.

Co-authorship network of co-authors of James H. Kocsis

This figure shows the co-authorship network connecting the top 25 collaborators of James H. Kocsis. A scholar is included among the top collaborators of James H. Kocsis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James H. Kocsis. James H. Kocsis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Difede, JoAnn, Andrew A. McAleavey, Katarzyna Wyka, et al.. (2023). A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment. Contemporary Clinical Trials Communications. 33. 101116–101116. 4 indexed citations

Nasca, Carla, Benedetta Bigio, Kathleen Watson, et al.. (2020). Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance. Molecular Psychiatry. 26(9). 5140–5149. 81 indexed citations

Kamali, Masoud, Noreen A. Reilly-Harrington, Weilynn C. Chang, et al.. (2019). Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship. Journal of Affective Disorders. 259. 164–172. 12 indexed citations

Furukawa, Toshi A., Elisabeth Schramm, Erica Weitz, et al.. (2016). Cognitive-Behavioural Analysis System of Psychotherapy (CBASP), a drug, or their combination: differential therapeutics for persistent depressive disorder: a study protocol of an individual participant data network meta-analysis. BMJ Open. 6(5). e011769–e011769. 12 indexed citations

Tennakoon, Lakshika, Jennifer Keller, Jane Sarginson, et al.. (2014). ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression. The Pharmacogenomics Journal. 15(4). 332–339. 28 indexed citations

Steidtmann, Dana, Rachel Manber, Christine Blasey, et al.. (2013). Detecting critical decision points in psychotherapy and psychotherapy + medication for chronic depression.. Journal of Consulting and Clinical Psychology. 81(5). 783–792. 22 indexed citations

Thoma, Nathan C., et al.. (2011). A Quality-Based Review of Randomized Controlled Trials of Cognitive-Behavioral Therapy for Depression: An Assessment and Metaregression. American Journal of Psychiatry. 169(1). 22–30. 55 indexed citations

Thase, Michael E., Alan J. Gelenberg, Susan G. Kornstein, et al.. (2010). Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: Results from the PREVENT study. Journal of Psychiatric Research. 45(3). 412–420. 19 indexed citations

Kocsis, James H.. (2009). Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic Depression<subtitle>The REVAMP Trial</subtitle><alt-title>Augmentation With CBASP and BSP for Depression</alt-title>. Archives of General Psychiatry. 66(11). 1178–1178. 131 indexed citations

10.

Gelenberg, Alan J., Michael E. Thase, Roger E. Meyer, et al.. (2008). The History and Current State of Antidepressant Clinical Trial Design. The Journal of Clinical Psychiatry. 69(10). 1513–1528. 59 indexed citations

11.

Kornstein, Susan G., James H. Kocsis, Saeeduddin Ahmed, et al.. (2008). Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study. International Clinical Psychopharmacology. 23(6). 357–363. 13 indexed citations

12.

Markowitz, John C., et al.. (2008). Pilot Study of Interpersonal Psychotherapy Versus Supportive Psychotherapy for Dysthymic Patients With Secondary Alcohol Abuse or Dependence. The Journal of Nervous and Mental Disease. 196(6). 468–474. 39 indexed citations

13.

Kocsis, James H., Michael E. Thase, Madhukar H. Trivedi, et al.. (2007). Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study. The Journal of Clinical Psychiatry. 68(7). 1014–1023. 46 indexed citations

14.

Kocsis, James H.. (2006). Recurrent Depression:Patient Characteristics, Clinical Course, and Current Recommendations for Management. CNS Spectrums. 11(S15). 6–11. 6 indexed citations

15.

Thase, Michael E., A. John Rush, Robert H. Howland, et al.. (2002). Double-blind Switch Study of Imipramine or Sertraline Treatment of Antidepressant-Resistant Chronic Depression. Archives of General Psychiatry. 59(3). 233–233. 103 indexed citations

16.

Gelenberg, Alan J., Susan G. Kornstein, Robert H. Howland, et al.. (2001). Sertraline versus imipramine to prevent relapse in chronic depression. Journal of Affective Disorders. 65(1). 27–36. 53 indexed citations

17.

Harden, Cynthia L., Lawrence H. Pick, Blagovest Nikolov, et al.. (1999). A Beneficial Effect on Mood in Partial Epilepsy Patients Treated with Gabapentin. Epilepsia. 40(8). 1129–1134. 60 indexed citations

18.

Brown, Richard P., et al.. (1984). Involutional melancholia revisited. American Journal of Psychiatry. 141(1). 24–28. 92 indexed citations

19.

Kalman, Thomas P., et al.. (1982). A controlled study of satisfaction among psychobiology research patients. American Journal of Psychiatry. 139(3). 344–347. 13 indexed citations

20.

Kocsis, James H., et al.. (1978). High-dose lithium therapy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(6). 759–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact